Intelligent Patient-Controlled Liquid Oral Medicine Dispenser and Deactivation System

Publication ID: 24-11857504_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Patient-Controlled Liquid Oral Medicine Dispenser and Deactivation System,” Published Technical Disclosure No. 24-11857504_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857504_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,504.

Summary of the Inventive Concept

A synergistic system integrating a patient-controlled liquid oral medicine dispenser and deactivation system with AI, IoT, blockchain, and nanomaterial technologies to provide secure, personalized, and adaptive medication management.

Background and Problem Solved

The original patent addressed the limitations of invasive patient-controlled medication administration methods, including complexity, infection risks, and diversion potential. The new inventive concept builds upon this foundation by incorporating advanced technologies to overcome the remaining challenges, such as medication adherence, diversion prevention, and real-time monitoring.

Detailed Description of the Inventive Concept

The intelligent system comprises a patient-controlled liquid oral medicine dispenser and deactivation system integrated with an AI-powered medication management platform, IoT sensors, a blockchain-based ledger, and a nanomaterial-based sensor. The AI platform monitors and adapts to patient behavior to optimize medication dosing and prevent diversion. IoT sensors track medication usage patterns and transmit data to a remote server for analysis and feedback. The blockchain-based ledger records and verifies medication administration events, ensuring tamper-proof tracking. The nanomaterial-based sensor detects and responds to medication tampering or diversion attempts. The system can be implemented in various forms, including wearable devices and smart medication containers, to provide personalized medication recommendations and alerts.

Novelty and Inventive Step

The new claims introduce the novel combination of AI, IoT, blockchain, and nanomaterial technologies with the patient-controlled liquid oral medicine dispenser and deactivation system, providing a synergistic solution that addresses the limitations of the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful, secure, and adaptive medication management system.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the system with electronic health records, using machine learning algorithms to predict patient behavior, or incorporating additional sensors to monitor medication efficacy. Variations may include using different AI platforms, IoT protocols, or blockchain architectures to achieve the same synergistic effect.

Potential Commercial Applications and Market

The intelligent patient-controlled liquid oral medicine dispenser and deactivation system has significant commercial potential in the healthcare industry, particularly in the areas of medication management, patient safety, and personalized medicine. Target markets may include hospitals, clinics, pharmacies, and healthcare technology companies.

CPC Classifications

SectionClassGroup
A A61 A61J7/0053
A A61 A61J1/22
G G16 G16H20/13
A A61 A61J2200/30
A A61 A61J2200/70

Original Patent Information

Patent NumberUS 11,857,504
TitlePatient-controlled liquid oral medicine dispenser and deactivation system
Assignee(s)Yale University